U.S., Sept. 17 -- ClinicalTrials.gov registry received information related to the study (NCT07174414) titled 'Cilostazol for Prevention of Recurrent Stroke Trial' on Sept. 12.
Brief Summary: The goal of this clinical trial is to learn whether adding cilostazol to aspirin or clopidogrel prevents stroke and heart attack in people who have had a stroke or mini-stroke.
Study Start Date: Aug., 2026
Study Type: INTERVENTIONAL
Condition:
Stroke Recurrence
Myocardial Infarction
Vascular Death
Ischemic Stroke
TIA (Transient Ischemic Attack)
Stroke (CVA) or Transient Ischemic Attack
Recurrent Stroke
Intervention:
DRUG: Cilostazol 100 mg
Cilostazol 100 mg tablet taken orally twice daily following an initial 2-week period during which cilostazo...